In an unprecedented procedure, CRISPR gene editing has been used to treat cancer.
A research team from Tel Aviv University, led by Razan Masarwy, successfully used CRISPR to cut a gene from head and neck cancers. Following the procedure, 50 percent of the targeted tumors disappeared 84 days after treatment. Their findings were published in Advanced Science.
Collapsing the Cancer Pyramid
Dan Peer, Director of the Laboratory of Precision Nanomedicine, and his colleagues are pioneers in mRNA-based therapeutics and drug development. In 2020, the team was the first in the world to use CRISPR to cut genes from cancer cells in mice and are now the first to apply the same procedure to head and neck cancers.
